Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 1;28(5):3393-3402.
doi: 10.3390/curroncol28050293.

Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges

Alessandro Rizzo  1   2 , Vincenzo Dadduzio  2 , Lucia Lombardi  2 , Angela Dalia Ricci  1   2 , Gennaro Gadaleta-Caldarola  2
Affiliations
Review

Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges

Alessandro Rizzo et al. Curr Oncol. .

Abstract

Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all gastrointestinal solid tumors and 20% of all periampullary cancers (PACs). Unfortunately, few data are available regarding the optimal therapeutic strategy for ACs due to their rarity, and physicians frequently encounter significant difficulties in the management of these malignancies. In this review, we will provide an overview of current evidence on AC, especially focusing on biological features, histological characteristics, and available data guiding present and future therapeutic strategies for these rare, and still barely known, tumors.

Keywords: adenocarcinoma; ampulla of Vater cancer; ampullary cancer; biliary tract cancer; chemotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the ampulla of Vater.
See this image and copyright information in PMC

References

    1. Ahn D.H., Bekaii-Saab T. Ampullary Cancer: An Overview. Am. Soc. Clin. Oncol. Educ. Book. 2014;34:112–115. doi: 10.14694/EdBook_AM.2014.34.112. - DOI - PMC - PubMed
    1. Zheng-Pywell R., Reddy S. Ampullary Cancer. Surg. Clin. N. Am. 2019;99:357–367. doi: 10.1016/j.suc.2018.12.001. - DOI - PubMed
    1. Saha S.K., Zhu A.X., Fuchs C.S., Brooks G.A. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Oncologist. 2016;21:594–599. doi: 10.1634/theoncologist.2015-0446. - DOI - PMC - PubMed
    1. Fischer H.-P., Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J. Hepato-Biliary-Pancreat. Surg. 2004;11:301–309. doi: 10.1007/s00534-004-0898-3. - DOI - PubMed
    1. Alessandrino F., Ivanovic A.M., Yee E.U., Radulovic D., Souza D., Mortele K.J. MDCT and MRI of the ampulla of Vater. Part I: Technique optimization, normal anatomy, and epithelial neoplasms. Abdom. Imaging. 2015;40:274–291. doi: 10.1007/s00261-015-0528-3. - DOI - PubMed

LinkOut - more resources